Sunflower Pharmaceutical Group Co.,Ltd (SHE:002737)

China flag China · Delayed Price · Currency is CNY
15.69
+0.06 (0.38%)
Apr 30, 2025, 3:04 PM CST
-39.47%
Market Cap 9.16B
Revenue (ttm) 2.52B
Net Income (ttm) 293.97M
Shares Out 584.00M
EPS (ttm) 0.50
PE Ratio 31.15
Forward PE n/a
Dividend 0.50 (3.19%)
Ex-Dividend Date Jun 14, 2024
Volume 3,109,463
Average Volume 4,996,668
Open 15.50
Previous Close 15.63
Day's Range 15.50 - 15.77
52-Week Range 15.50 - 30.79
Beta 0.32
RSI 24.17
Earnings Date Apr 25, 2025

About SHE:002737

Sunflower Pharmaceutical Group Co.,Ltd engages in the research and development, manufacturing, and marketing of Chinese patent medicines in China and internationally. The company produces chemical and biological medicines, and health care products. It also provides products covering various therapeutic areas, including pediatrics, gynecology, digestive system, respiratory and cold, rheumatic bone disease, and cardiovascular and cerebrovascular; supplements; and antibiotics and children’s medicinal products. The company sells its products under ... [Read more]

Sector Healthcare
Founded 2005
Employees 5,727
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002737
Full Company Profile

Financial Performance

In 2024, SHE:002737's revenue was 3.38 billion, a decrease of -40.76% compared to the previous year's 5.70 billion. Earnings were 492.05 million, a decrease of -56.03%.

Financial Statements

News

There is no news available yet.